FDA Releases Summary Data on Cosmetic Facility and Product Registration under MoCRA

On March 13, 2025, the U.S. Food and Drug Administration (FDA) published new summary data on the mandatory registration of cosmetic product facilities and the listing of cosmetic products. This milestone is part of the agency’s ongoing implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)—the most significant update to U.S. cosmetics oversight in over 80 years.

What MoCRA Requires

Under MoCRA, any manufacturer or processor that distributes cosmetic products in the United States must:

  • Register their facilities with the FDA and renew every two years.
  • List each marketed cosmetic product with the FDA, including a full list of product ingredients.
  • Update product listings annually to ensure accuracy and transparency.

While there are exemptions—such as for certain small businesses and for products already regulated as drugs or devices—most cosmetics manufacturers and processors are now subject to these mandatory requirements.

Why This Matters

Before MoCRA, cosmetic facility registration and product listing were voluntary. The shift to mandatory compliance marks a major step forward in the FDA’s ability to:

  • Track where cosmetic products are made.
  • Identify and address potential safety issues faster.
  • Provide more transparency for consumers and industry stakeholders.

By compiling and publishing this data, the FDA is making it easier to see the scale of industry participation and to hold companies accountable for safety and labeling standards.

Accessing the Data

The FDA’s public database includes tabulated registration and listing figures and can be accessed on the Registration and Listing of Cosmetic Product Facilities and Products webpage. The agency has also published its Guidance for Industry to help businesses understand how to comply with these new requirements.

The Bigger Picture

This update reflects MoCRA’s broader goal—strengthening cosmetic safety oversight by equipping the FDA with better information and regulatory tools. For manufacturers, the message is clear: transparency and compliance are no longer optional. For consumers, these changes promise a higher level of safety and trust in the products they use daily.

Back to blog